Sabre Insurance Group PLC Exercise of Overallotment Option (2919Z)
14 December 2017 - 4:44AM
UK Regulatory
TIDMSBRE
RNS Number : 2919Z
Sabre Insurance Group PLC
13 December 2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF
AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER
JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS
ANNOUNCEMENT
For Immediate Release
13 December 2017
SABRE INSURANCE GROUP PLC
Exercise of Overallotment Option
Further to its announcement on 6 December 2017 relating to its
initial public offering (the "Offer"), Sabre Insurance Group plc
(the "Company") confirms that Barclays Bank PLC, as stabilisation
manager, has exercised in its entirety the over-allotment option
granted by BC European Capital IX, a private equity fund advised by
BC Partners LLP ("BC European Capital"), in respect of 12,500,000
ordinary shares of GBP0.001 ("Ordinary Shares") each in the capital
of the Company (the "Over-allotment Shares"), taking the total
number of Ordinary Shares that were subject to the Offer to
137,500,000. The Over-allotment Shares will be sold at the offer
price of 230 pence per Ordinary Share.
Following the Offer and the exercise of the over-allotment
option, BC European Capital will hold 72,619,567 Ordinary Shares
being equal to 29.0 per cent. of the total issued share capital of
the Company.
Enquiries
Evercore Partners International LLP
Financial Adviser to the Company
Mark Hennessy
Jim Renwick +44 (0)20 7653 6000
Tulchan Communications
Financial Communications Adviser to the Company
James Macey White
Michelle Clarke +44 (0)20 7353 4200
Ticker: SBRE
SEDOL: BYWVDP4
ISIN: GB00BYWVDP49
LEI: 2138006RXRQ8P8VKGV98
Important Notice
This announcement does not constitute, or form part of, an offer
to sell, or a solicitation of an offer to purchase, any securities
in the United States of America, Australia, Canada, Japan or South
Africa or in any jurisdiction in which such offer or solicitation
is unlawful.
Neither this announcement nor any copy of it may be made or
transmitted into the United States of America, or distributed,
directly or indirectly, in the United States of America. Neither
this announcement nor any copy of it may be taken or transmitted
directly or indirectly into Australia, Canada, Japan or South
Africa or to any persons in any of those jurisdictions, except in
compliance with applicable securities laws. Any failure to comply
with this restriction may constitute a violation of United States,
Australian, Canadian, Japanese or South African securities laws.
The distribution of this announcement in other jurisdictions may be
restricted by law and persons into whose possession this
announcement comes should inform themselves about, and observe, any
such restrictions.
The securities referred to herein have not been, and will not
be, registered under the US Securities Act of 1933, as amended (the
"Securities Act"), or with any securities regulatory authority of
any state or other jurisdiction of the United States of America and
may not be offered or sold in the United States of America except
pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act and in
compliance with such other applicable laws. There will be no public
offering of the securities in the United States of America. The
securities referred to herein have not been registered under the
applicable securities laws of, Canada, Australia, Japan or South
Africa and, subject to certain exceptions, may not be offered or
sold within Canada, Australia, Japan or South Africa or to any
national, resident or citizen of Canada, Australia, Japan or South
Africa.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUOSBRBUAUAAA
(END) Dow Jones Newswires
December 13, 2017 12:44 ET (17:44 GMT)
Sabre Insurance (LSE:SBRE)
Historical Stock Chart
From Apr 2024 to May 2024
Sabre Insurance (LSE:SBRE)
Historical Stock Chart
From May 2023 to May 2024